More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from ...
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
It could be a medical condition called essential tremor, and a new study by Singapore’s National Neuroscience Institute has ...
Paraquat exposure and its link to Parkinson’s disease is leading to policy battles within California and nationwide.
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Moderate- or high-intensity exercise can help with Parkinson's disease symptoms like fatigue, a recent study shows.
A recent study suggests that a class of diabetes medications could be linked to a reduced risk of developing dementia ...
Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...